| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide cardiometabolic and GLP-1 solutions to a national employer (the "Employer") beginning in January 2024.
The Employer, a national logistics company, selected Dario to deliver integrated support for employees living with diabetes, pre-diabetes, weight management and hypertension, while also providing a tailored experience for employees taking a GLP-1 medication. Dario combines intelligent technologies and expert human support with billions of data insights gathered from a decade of consumer engagement to deliver highly personalized experiences that keep people engaged over time for optimal results.
"GLP-1 medications are creating tremendous upheaval for employers and payers, and our new contract with the Employer is a great example of how Dario is helping employers address the growing and costly problem. Dario's solutions have been proven, in prior studies, to deliver long-term behavior change with and without a GLP-1 medication to help employers like the Employer realize the full potential in health outcomes," said Rick Anderson, President of Dario.
About Dario's GLP-1 solution
Dario's GLP-1 solution delivers the U.S. Food and Drug Administration (FDA) required behavior change support component to members enrolled in the cardiometabolic solution before or during use of a GLP-1. Members using a GLP-1 or other anti-obesity medication receive a highly personalized experience optimizing digital coaching and professional human support, including guidance from a Certified Diabetes Educator, to improve overall health.
As part of their experience, members have access to Dario's Medication Cabinet, a digital tool to help members track medication adherence, along with tailored lifestyle change programs and tools to support sustainable behavior change.
Data insights available as part of Dario's solution help partners better understand member adherence and the impact on overall member health.
Posted In: DRIO
